Abstract
Once metastatic, prostate cancer was regarded as a systemic disease that is not amenable to surgical therapy. We present a case of a solitary pulmonary recurrence of prostate cancer after radical prostatectomy that was resected, resulting in 12 years of biochemical remission without additional therapy.
MeSH terms
-
Adenocarcinoma / blood
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / secondary*
-
Adenocarcinoma / surgery
-
Aged
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Biomarkers, Tumor / blood*
-
Combined Modality Therapy
-
Cough
-
Disease-Free Survival
-
Dyspnea / etiology
-
Flutamide / therapeutic use
-
Follow-Up Studies
-
Humans
-
Leuprolide / therapeutic use
-
Lung Neoplasms / blood
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary*
-
Lung Neoplasms / surgery
-
Male
-
Neoplasm Proteins / blood*
-
Pneumonectomy
-
Prostate-Specific Antigen / blood*
-
Prostatectomy
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / surgery*
-
Remission Induction
Substances
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
Neoplasm Proteins
-
Flutamide
-
Prostate-Specific Antigen
-
Leuprolide